Oropharyngeal Cancer Diagnosis and Therapeutics Market
Global Oropharyngeal Cancer Diagnosis And Therapeutics Market Size, Share & Trends Analysis Report by Diagnosis Type (Endoscopy, Biopsy, Imaging, MRI Scan, CT Scan, and PET-CT Scan), by Treatment Type (Surgery, Chemotherapy, Radiation Therapy, Targeted Therapy, and Others) and by End-Users (Hospitals, Ambulatory Surgery Centers, and Others) Forecast Period (2022-2028) Update Available - Forecast 2024-2030
The global oropharyngeal cancer diagnosis and therapeutics market are anticipated to grow at a significant CAGR of 4.5% during the forecast period. Oropharyngeal cancer is a malignant tumor that starts in the cells of the oropharynx. The rising prevalence of oropharyngeal cancer has been the major factor driving market growth. More than 400,000 incidences of oropharyngeal cancer are reported every year globally. Moreover, the growing number of smokers tobacco consumption and alcohol consumers who are most prone to this cancer has been a major factor in the oropharyngeal cancer diagnosis and therapeutics market growth. For instance, according to WHO, as of 2021, tobacco kills more than 8 million people each year. More than 7 million of those deaths are the result of direct tobacco use while around 1.2 million are the result of non-smokers being exposed to second-hand smoke.
Impact of COVID-19 Pandemic on Global Oropharyngeal Cancer Diagnosis and Therapeutics Market
The havoc caused by the COVID-19 pandemic continues to disrupt daily life and negatively impacted the market. Hospitals and clinics have shifted daily resources to cope with an influx of patients with COVID-19 disease, forcing cancer patients to weigh the potential benefit of a face-to-face visit and treatment with the risks of catching the virus. Moreover, due to the lockdowns in various countries, the demand for oral cancer treatment has significantly reduced due to the restriction of people from moving freely and also people avoiding much of their visits to the health care places until there’s an emergency.
Segmental Outlook
The global oropharyngeal cancer diagnosis and therapeutics market are segmented based on the diagnostic type, treatment type, and end-users. Based on the diagnostic type, the market is segmented into endoscopy, biopsy, imaging, MRI scan, CT scan, and PET-CT scan. Based on the treatment type, the market is sub-segmented into surgery, chemotherapy, radiation therapy, targeted therapy, and others. Based on the end-users, the market is augmented into hospitals, ambulatory surgery centers, and others. The above-mentioned segments can be customized as per the requirements. Among the diagnostic type, the CT Scan segment is expected to be the fastest-growing segment in the market over the forecast period. CT Scan is widely used to diagnose oropharyngeal cancer as it makes a series of detailed pictures of areas inside the body, such as the head, neck, chest, and lymph nodes, taken from different angles.
Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Treatment Type, 2021 (%)
The Chemotherapy Segment is Expected to Hold a Significant Share in the Market
Among the treatment segment, the chemotherapy segment is expected to hold a considerable share in the market over the forecast period. Chemotherapy may shrink patients’ cancer or slow down its growth, which helps them to live longer and help with their symptoms. For a small number of people with borderline resectable cancer, chemotherapy may shrink cancer enough to make surgery to remove cancer possible. According to the American Cancer Society, the II stage patients receive surgery followed by chemotherapy (60%), radiation (24%), or both (1%).
Regional Outlooks
The global oropharyngeal cancer diagnosis and therapeutics market are further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa, and Latin America). The market can be analyzed for a particular region or country level as per the requirement. Among all regions, the Asia-Pacific is expected to be the fastest-growing region during the forecast period due to the rising geriatric population and increasing incidence and prevalence rate of oropharyngeal cancer.
Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Growth, by Region 2022-2028
The North America Region is Expected to hold the Considerable Share of the Market
The North American region is expected to hold a considerable share in the global oropharyngeal cancer diagnosis and therapeutics market due to its well-established health infrastructure and the high prevalence of this cancer in people. The players in the region are providing technology to deploy software across imaging networks and helping to make the newest innovations accessible across the broader population. For instance, in November 2021, GE Healthcare announced collaborations with SOPHiA GENETICS, the University of Cambridge, and Optellum as part of its vision to advance care, make precision health more accessible, and ultimately improve outcomes for cancer patients.
Market Players Outlook
The major companies serving the global oropharyngeal cancer diagnosis and therapeutics market include AstraZeneca Plc, Bayer AG, Boston Biomedical, Inc., Bristol-Myers Squibb Co., GE Healthcare, Inovio Pharmaceuticals, Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in April 2022, GE Healthcare and Elekta announced that they have signed a global commercial collaboration agreement in the field of radiation oncology, enabling the two companies to provide hospitals with a comprehensive offering across imaging and treatment for cancer patients requiring radiation therapy.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global oropharyngeal cancer diagnosis and therapeutics market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the Global Oropharyngeal Cancer Diagnosis and Therapeutics Market
• Recovery Scenario of Global OROPHARYNGEAL Cancer Diagnosis and Therapeutics Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Key Strategy Analysis
3.3. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Diagnosis Type
4.1.1. Endoscopy
4.1.2. Biopsy
4.1.3. Imaging
4.1.4. MRI Scan
4.1.5. CT Scan
4.1.6. Pet-CT Scan
4.2. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Treatment Type
4.2.1. Surgery
4.2.2. Chemotherapy
4.2.3. Radiation Therapy
4.2.4. Targeted Therapy
4.2.5. Others
4.3. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market End-Users
4.3.1. Hospitals
4.3.2. Ambulatory Surgery Centers
4.3.3. Others
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Ab Sciences
6.2. Advaxis Inc.
6.3. AstraZeneca Plc
6.4. Bayer AG
6.5. Boston Biomedical, Inc.
6.6. Bristol-Myers Squibb Co.
6.7. GE Healthcare
6.8. Immunovaccine, Inc.
6.9. Inovio Pharmaceuticals, Inc.
6.10. Merck & Co. Inc.
6.11. Novartis AG
6.12. PNP Therapeutics Inc.
6.13. Synta Pharmaceuticals Corp.
6.14. Vlpbio
1. GLOBAL OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS DIAGNOSIS TYPE, 2021-2028 ($ MILLION)
2. GLOBAL OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS BY ENDOSCOPY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS BY BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS BY IMAGING MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS BY MRI SCAN MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS BY CT SCAN MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7. GLOBAL OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS BY PET-CT SCAN MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS TREATMENT TYPE, 2021-2028 ($ MILLION)
9. GLOBAL OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS BY SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10. GLOBAL OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS BY CHEMOTHERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11. GLOBAL OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS BY RADIATION THERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12. GLOBAL OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS BY TARGETED THERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
13. GLOBAL OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS BY OTHER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
14. GLOBAL OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS END-USERS, 2021-2028 ($ MILLION)
15. GLOBAL OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS FOR HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
16. GLOBAL OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS FOR AMBULATORY SURGERY CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
17. GLOBAL OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS FOR OTHER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
18. GLOBAL OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
19. NORTH AMERICAN OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
20. NORTH AMERICAN OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS DIAGNOSIS TYPE, 2021-2028 ($ MILLION)
21. NORTH AMERICAN OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS TREATMENT TYPE, 2021-2028 ($ MILLION)
22. NORTH AMERICAN OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS END-USERS, 2021-2028 ($ MILLION)
23. EUROPEAN OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
24. EUROPEAN OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS DIAGNOSIS TYPE, 2021-2028 ($ MILLION)
25. EUROPEAN OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS TREATMENT TYPE, 2021-2028 ($ MILLION)
26. EUROPEAN OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS END-USERS, 2021-2028 ($ MILLION)
27. ASIA-PACIFIC OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
28. ASIA-PACIFIC OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS DIAGNOSIS TYPE, 2021-2028 ($ MILLION)
29. ASIA-PACIFIC OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS TREATMENT TYPE, 2021-2028 ($ MILLION)
30. ASIA-PACIFIC OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS END-USERS, 2021-2028 ($ MILLION)
31. REST OF THE WORLD OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
32. REST OF THE WORLD OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS DIAGNOSIS TYPE, 2021-2028 ($ MILLION)
33. REST OF THE WORLD OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS TREATMENT TYPE, 2021-2028 ($ MILLION)
34. REST OF THE WORLD OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET RESEARCH AND ANALYSIS END-USERS, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET, 2021-2028 (%)
4. GLOBAL OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET SHARE DIAGNOSIS TYPE, 2021 VS 2028 (%)
5. GLOBAL OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS BY ENDOSCOPY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS BY BIOPSY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS BY IMAGING MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8. GLOBAL OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS BY MRI SCAN MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9. GLOBAL OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS BY CT SCAN MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10. GLOBAL OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS BY PET-CT SCAN MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11. GLOBAL OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET SHARE TREATMENT TYPE, 2021 VS 2028 (%)
12. GLOBAL OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS BY SURGERY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13. GLOBAL OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS BY CHEMOTHERAPY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
14. GLOBAL OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS BY RADIATION THERAPY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
15. GLOBAL OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS BY TARGETED THERAPY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
16. GLOBAL OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS BY OTHER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
17. GLOBAL OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET SHARE END-USERS, 2021 VS 2028 (%)
18. GLOBAL OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS FOR HOSPITALS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
19. GLOBAL OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS FOR AMBULATORY SERVICE CENTERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
20. GLOBAL OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS FOR OTHER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
21. GLOBAL OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
22. US OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, 2021-2028 ($ MILLION)
23. CANADA OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, 2021-2028 ($ MILLION)
24. UK OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, 2021-2028 ($ MILLION)
25. FRANCE OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, 2021-2028 ($ MILLION)
26. GERMANY OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, 2021-2028 ($ MILLION)
27. ITALY OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, 2021-2028 ($ MILLION)
28. SPAIN OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, 2021-2028 ($ MILLION)
29. REST OF EUROPE OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, 2021-2028 ($ MILLION)
30. INDIA OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, 2021-2028 ($ MILLION)
31. CHINA OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, 2021-2028 ($ MILLION)
32. JAPAN OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, 2021-2028 ($ MILLION)
33. SOUTH KOREA OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, 2021-2028 ($ MILLION)
34. REST OF ASIA-PACIFIC OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, 2021-2028 ($ MILLION)
35. REST OF THE WORLD OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS MARKET SIZE, 2021-2028 ($ MILLION)
